OneSource Specialty Pharma Limited (ONESOURCE) Financial History

Name: OneSource Specialty Pharma Limited (ONESOURCE) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-09-20

OneSource Specialty Pharma Limited (ONESOURCE) operates in the Biotechnology industry and is headquartered in Bengaluru, India with about 1,674 employees. Its market capitalization is roughly ₹183 billion. In the fiscal year ended 2026-03-31, ONESOURCE reported ₹14.2B in revenue and (₹738M) in net income.

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally.

Interactive charts & full statements →

ONESOURCE Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹14.2B	₹14.4B	₹1.7B	₹387M
Gross Profit	₹9.8B	₹10.1B	₹1.0B	₹183M
Operating Income (EBIT)	(₹55M)	₹1.9B	(₹1.6B)	(₹2.2B)
Net Income	(₹738M)	(₹180M)	(₹3.9B)	(₹8.0B)

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ONESOURCE Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	₹4.5B	₹4.3B	₹2.9B	₹3.8B	₹3.3B	—
Gross Profit	₹3.1B	₹2.8B	₹2.0B	₹2.6B	₹2.3B	—
Operating Income (EBIT)	₹516M	₹201M	(₹523M)	₹367M	₹207M	—
Net Income	₹250M	₹46M	(₹887M)	₹105M	(₹2M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ONESOURCE Free Cash Flow History

ONESOURCE Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Assets	₹82.1B	₹75.5B	₹13.1B	₹20.1B
Total Liabilities	₹23.8B	₹16.7B	₹9.1B	₹12.2B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ONESOURCE viewer.

Other Companies in Biotechnology

ABBV · AbbVie — $466 billion
6160 · BeOne Medicines AG — HK$313 billion
AMGN · Amgen — $208 billion
GILD · Gilead Sciences — $186 billion
CONCORDBIO · Concord Biotech Limited — ₹156 billion
4587 · PeptiDream Inc. — JPY 138 billion
VRTX · Vertex Pharmaceuticals — $129 billion
4565 · Nxera Pharma Co., Ltd. — JPY 119 billion

← ONEQ All “O” companies ONEV →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.